Literature DB >> 31262313

Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.

Ronald Labonté1, Eric Crosbie2, Deborah Gleeson3, Courtney McNamara4.   

Abstract

Following publication of the original article [1], the authors flagged an error concerning two missing article references, which were unfortunately not provided prior to publication of the article.

Entities:  

Year:  2019        PMID: 31262313      PMCID: PMC6604388          DOI: 10.1186/s12992-019-0482-x

Source DB:  PubMed          Journal:  Global Health        ISSN: 1744-8603            Impact factor:   4.185


Correction to: Globalization and Health (2019) 15:35. https://doi.org/10.1186/s12992-019-0476-8 Following publication of the original article [1], the authors flagged an error concerning two missing article references, which were unfortunately not provided prior to publication of the article. The two missing references are: Firstly: Lexchin, J. (2019) Increase in drug spending in Canada due to extension of data protection for biologics: a descriptive study. Healthcare Policy 14 (3) 10–18.doi:10.12927/hcpol.2019.25796 This should be referenced under the sub-heading ‘Pharmaceuticals and access to medicines’ in place of the first two (under this sub-heading) references to reference ‘9’. Secondly: O’Brien P, Gleeson D, Room R, Wilkinson C. Marginalising health information: implications of the Trans Pacific Partnership for alcohol labelling. Melbourne University Law Review. 2017;41(1):341–91. This should be referenced under the sub-heading ‘Agriculture’ in place of the second (under this sub-heading) reference to reference ‘30’. The authors apologize for this error.
  1 in total

Review 1.  USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.

Authors:  Ronald Labonté; Eric Crosbie; Deborah Gleeson; Courtney McNamara
Journal:  Global Health       Date:  2019-05-14       Impact factor: 4.185

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.